Identification of allogeneic and xenogeneic neural stem cells' immunogenicity in the brain and strategies to alleviate transplantation rejection
Transplant Immunology · 2025-09 · 92 · 102247
DOI: 10.1016/j.trim.2025.102247 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant Immunology, 2025-09. Verfasst von Xiangyu Ma und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy & Cell Biology, Sungkyunkwan University School of Medicine, Suwon 16419, South Korea. Hauptthemen laut MEDLINE: Graft Rejection, Neural Stem Cells, Brain. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Korea Basic Science Institute, the Korea Basic Science Institute, Korea Health Industry Development Institute.
Abstract (Originalsprache)
Neural stem cells (NSCs) are a promising therapy for central nervous system (CNS) disorders, yet post-transplant immune rejection critically compromises their survival and efficacy. In this study, we demonstrated the neuroinflammatory responses triggered by syngeneic, allogeneic, and xenogeneic NSCs transplantation, and evaluated the immunosuppressive effects of cyclosporine A (CyA) and methylprednisolone (MP) on graft rejection. Our findings revealed that xenogeneic NSCs transplantation induced infiltration of neutrophils (p < 0.0001), microglia/macrophages (p < 0.0001), CD4+ and CD8+ T cells (p < 0.0001), while allogeneic transplantation primarily triggered microglia/macrophages (p < 0.0005) recruitment. Both transplantation types caused a sharp decline in grafted cell numbers (p < 0.005). Combinatorial CyA and MP treatment significantly attenuated xenogeneic immune rejection and markedly increased surviving graft cells in the brain. Similarly, MP monotherapy effectively reduced allogeneic rejection and enhanced transplanted cell survival. Overall, allogeneic NSCs transplantation primarily triggers innate immunity, while xenogeneic transplantation causes both innate and adaptive immune responses. Accordingly, xenogeneic transplantation required combined CyA and MP therapy, whereas MP monotherapy mitigated rejection in allogeneic transplantation. Our findings may offer a strategy to mitigate transplantation rejection of allogeneic and xenogeneic NSCs in the brain, thereby optimizing the microenvironment for NSC-based therapies in preclinical and clinical applications for various CNS disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomy & Cell Biology, Sungkyunkwan University School of Medicine, Suwon 16419, South Korea.
- Medical Innovation Technology Inc. (MEDINNO Inc.), Seoul 08517, South Korea.
- Medical Innovation Technology Inc. (MEDINNO Inc.), Seoul 08517, South Korea; Stem Cell and Regenerative Medicine Institute, Research Institute for Future Medicine, Samsung Medical Center, Seoul 06351, South Korea; Depar…
- Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, South Korea.
- Stem Cell and Regenerative Medicine Institute, Research Institute for Future Medicine, Samsung Medical Center, Seoul 06351, South Korea; Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seo…
- Department of Anatomy & Cell Biology, Sungkyunkwan University School of Medicine, Suwon 16419, South Korea; Medical Innovation Technology Inc. (MEDINNO Inc.), Seoul 08517, South Korea; Stem Cell and Regenerative Medicin…
Förderung
- Korea Basic Science Institute
- the Korea Basic Science Institute
- Korea Health Industry Development Institute
- the Ministry of Health and Welfare, Republic of Korea
- Ministry of Health and Welfare
- Ministry of Education
Zitieren
APA
Ma, X., Lee, H. J., Kim, D. O., Kwon, Y. D., Ha, G. H., Kim, C. K., Nam, H., Yeon, J. Y., Lee, K., Lee, S. H., & Joo, K. M. (2025). Identification of allogeneic and xenogeneic neural stem cells' immunogenicity in the brain and strategies to alleviate transplantation rejection. Transplant Immunology, 92, 102247. https://doi.org/10.1016/j.trim.2025.102247
Vancouver
Ma X, Lee HJ, Kim DO, Kwon YD, Ha GH, Kim CK, et al. Identification of allogeneic and xenogeneic neural stem cells' immunogenicity in the brain and strategies to alleviate transplantation rejection. Transplant Immunology. 2025;92:102247. doi:10.1016/j.trim.2025.102247
BibTeX
@article{Ma2025,
author = {Ma, Xiangyu and Lee, Ho Jin and Kim, Dong Oh and Kwon, Young Do and Ha, Geun-Hyoung and Kim, Chung Kwon and Nam, Hyun and Yeon, Je Young and Lee, Kyunghoon and Lee, Sun-Ho and Joo, Kyeung Min},
title = {Identification of allogeneic and xenogeneic neural stem cells' immunogenicity in the brain and strategies to alleviate transplantation rejection},
journal = {Transplant Immunology},
year = {2025},
volume = {92},
pages = {102247},
doi = {10.1016/j.trim.2025.102247}
}
EUVIMED